Publication Name	World Journal of Clinical Cases
Manuscript ID	63794
Country	Portugal

Category	Oncology
Manuscript Type	Case Report
Article Title	Long-term response to avelumab and management of oligoprogression in Merkel cell carcinoma: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Inês Leão, Joana Marinho and Telma Costa
Funding Agency and Grant Number
Corresponding Author	Telma Costa, MD, Doctor, Department of Oncology, Centro Hospitalar Vila Nova de Gaia/Espinho, Rua Conceição Fernandes, Vila Nova de Gaia 4434-502, Portugal. telma.r.c.costa@gmail.com
Key Words	Merkel cell carcinoma; Unresectable tumor; Avelumab; Oligoprogression; Surgery; Chemotherapy; Case report
Core Tip	This report highlights the efficacy and long-term response of avelumab, on the management of a chemotherapy resistant advanced Merkel cell carcinoma (MCC). It shows also a successful approach to oligoprogression with local radical treatment, surgery and radiotherapy, while maintaining systemic therapy with avelumab. The results support the effectiveness of this strategy for the management of unresectable MCC.
Citation	Leão I, Marinho J, Costa T. Long-term response to avelumab and management of oligoprogression in Merkel cell carcinoma: A case report. World J Clin Cases 2021; 9(18): 4829-4836

Received	2021-02-08 11:29
Peer-Review Started	2021-02-08 11:33
To Make the First Decision
Return for Revision	2021-04-25 04:46
Revised	2021-05-04 15:45
Second Decision	2021-05-08 06:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-05-08 08:49
Articles in Press	2021-05-08 08:49
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-05-13 19:27
Typeset the Manuscript	2021-05-29 03:52

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com